Header Logo

Connection

Paul Carvey to Dopamine

This is a "connection" page, showing publications Paul Carvey has written about Dopamine.
Connection Strength

5.013
  1. Methamphetamine-induced vascular changes lead to striatal hypoxia and dopamine reduction. Neuroreport. 2011 Dec 07; 22(17):923-8.
    View in: PubMed
    Score: 0.370
  2. Prenatal lipopolysaccharide does not accelerate progressive dopamine neuron loss in the rat as a result of normal aging. Exp Neurol. 2009 Apr; 216(2):312-20.
    View in: PubMed
    Score: 0.301
  3. Progressive dopamine neuron loss following supra-nigral lipopolysaccharide (LPS) infusion into rats exposed to LPS prenatally. Exp Neurol. 2006 Jun; 199(2):499-512.
    View in: PubMed
    Score: 0.248
  4. Progressive dopamine neuron loss in Parkinson's disease: the multiple hit hypothesis. Cell Transplant. 2006; 15(3):239-50.
    View in: PubMed
    Score: 0.245
  5. Intra-parenchymal injection of tumor necrosis factor-alpha and interleukin 1-beta produces dopamine neuron loss in the rat. J Neural Transm (Vienna). 2005 May; 112(5):601-12.
    View in: PubMed
    Score: 0.228
  6. Prenatal exposure to the bacteriotoxin lipopolysaccharide leads to long-term losses of dopamine neurons in offspring: a potential, new model of Parkinson's disease. Front Biosci. 2003 Sep 01; 8:s826-37.
    View in: PubMed
    Score: 0.208
  7. Lipopolysaccharide (LPS)-induced dopamine cell loss in culture: roles of tumor necrosis factor-alpha, interleukin-1beta, and nitric oxide. Brain Res Dev Brain Res. 2002 Jan 31; 133(1):27-35.
    View in: PubMed
    Score: 0.187
  8. Tumor necrosis factor alpha is toxic to embryonic mesencephalic dopamine neurons. Exp Neurol. 2001 Jun; 169(2):219-30.
    View in: PubMed
    Score: 0.178
  9. Striatal trophic activity is reduced in the aged rat brain. Brain Res. 2000 Feb 21; 856(1-2):301-9.
    View in: PubMed
    Score: 0.163
  10. Pramipexole attenuates the dopaminergic cell loss induced by intraventricular 6-hydroxydopamine. J Neural Transm (Vienna). 2000; 107(2):159-76.
    View in: PubMed
    Score: 0.162
  11. Prenatal cocaine exposure reduces glial cell line-derived neurotrophic factor (GDNF) in the striatum and the carotid body of the rat: implications for DA neurodevelopment. Brain Res Dev Brain Res. 1999 Dec 10; 118(1-2):231-5.
    View in: PubMed
    Score: 0.161
  12. The magnitude of brain dopamine depletion from prenatal cocaine exposure is a function of uterine position. Neurotoxicol Teratol. 1998 Jul-Aug; 20(4):373-82.
    View in: PubMed
    Score: 0.146
  13. Uterine position determines the extent of dopamine reduction after chronic prenatal cocaine exposure. Ann N Y Acad Sci. 1998 May 30; 844:314-23.
    View in: PubMed
    Score: 0.145
  14. Partial purification of a pramipexole-induced trophic activity directed at dopamine neurons in ventral mesencephalic cultures. Brain Res. 1998 Apr 27; 791(1-2):137-45.
    View in: PubMed
    Score: 0.144
  15. Differentiation of mesencephalic progenitor cells into dopaminergic neurons by cytokines. Exp Neurol. 1998 Feb; 149(2):411-23.
    View in: PubMed
    Score: 0.142
  16. Loss of striatal DA innervation increases striatal trophic activity directed at DA neurons in culture. Exp Neurol. 1996 Aug; 140(2):184-97.
    View in: PubMed
    Score: 0.128
  17. Prenatal cocaine exposure and postnatal hypoxia independently decrease carotid body dopamine in neonatal rats. Neurotoxicol Teratol. 1996 May-Jun; 18(3):283-7.
    View in: PubMed
    Score: 0.125
  18. Hypoxia after prenatal cocaine attenuates striatal dopamine and neurotrophic activity. Neurotoxicol Teratol. 1994 Mar-Apr; 16(2):177-81.
    View in: PubMed
    Score: 0.108
  19. Alterations in striatal neurotrophic activity induced by dopaminergic drugs. Pharmacol Biochem Behav. 1993 Sep; 46(1):195-204.
    View in: PubMed
    Score: 0.104
  20. Effect of cocaine in early gestation on striatal dopamine and neurotrophic activity. Pediatr Res. 1993 Sep; 34(3):389-92.
    View in: PubMed
    Score: 0.104
  21. Striatal extracts from patients with Parkinson's disease promote dopamine neuron growth in mesencephalic cultures. Exp Neurol. 1993 Mar; 120(1):149-52.
    View in: PubMed
    Score: 0.101
  22. The potential use of a dopamine neuron antibody and a striatal-derived neurotrophic factor as diagnostic markers in Parkinson's disease. Neurology. 1991 May; 41(5 Suppl 2):53-8; discussion 59-60.
    View in: PubMed
    Score: 0.089
  23. Dopamine distribution and behavioral alterations resulting from dopamine infusion into the brain of the lesioned rat. J Neurosurg. 1991 Jan; 74(1):105-11.
    View in: PubMed
    Score: 0.087
  24. Dopaminergic alterations in cotreatments attenuating haloperidol-induced hypersensitivity. Pharmacol Biochem Behav. 1990 Feb; 35(2):291-300.
    View in: PubMed
    Score: 0.081
  25. Disappearance of a putative DA-neuron antibody following adrenal medulla transplantation: relationship to a striatal-derived DA neuron trophic factor. Prog Brain Res. 1990; 82:693-7.
    View in: PubMed
    Score: 0.081
  26. Striatal homogenates from animals chronically treated with haloperidol stimulate dopamine and GABA uptake in cultures of rostral mesencephalic tegmentum. Clin Neuropharmacol. 1989 Oct; 12(5):425-34.
    View in: PubMed
    Score: 0.079
  27. Dopaminergic and serotoninergic deficiencies in young adult rats prenatally exposed to the bacterial lipopolysaccharide. Brain Res. 2009 Apr 10; 1265:196-204.
    View in: PubMed
    Score: 0.076
  28. The effect of bilateral kainic acid-induced lateral habenula lesions on dopamine-mediated behaviors. Brain Res. 1987 Apr 14; 409(1):193-6.
    View in: PubMed
    Score: 0.067
  29. TNF-alpha knockout and minocycline treatment attenuates blood-brain barrier leakage in MPTP-treated mice. Neurobiol Dis. 2007 Apr; 26(1):36-46.
    View in: PubMed
    Score: 0.066
  30. 6-Hydroxydopamine-induced alterations in blood-brain barrier permeability. Eur J Neurosci. 2005 Sep; 22(5):1158-68.
    View in: PubMed
    Score: 0.060
  31. Age-dependent motor deficits and dopaminergic dysfunction in DJ-1 null mice. J Biol Chem. 2005 Jun 03; 280(22):21418-26.
    View in: PubMed
    Score: 0.058
  32. Rotenone potentiates dopamine neuron loss in animals exposed to lipopolysaccharide prenatally. Exp Neurol. 2004 Dec; 190(2):373-83.
    View in: PubMed
    Score: 0.057
  33. Combined toxicity of prenatal bacterial endotoxin exposure and postnatal 6-hydroxydopamine in the adult rat midbrain. Neuroscience. 2004; 124(3):619-28.
    View in: PubMed
    Score: 0.053
  34. In utero bacterial endotoxin exposure causes loss of tyrosine hydroxylase neurons in the postnatal rat midbrain. Mov Disord. 2002 Jan; 17(1):116-24.
    View in: PubMed
    Score: 0.046
  35. A clonal line of mesencephalic progenitor cells converted to dopamine neurons by hematopoietic cytokines: a source of cells for transplantation in Parkinson's disease. Exp Neurol. 2001 Sep; 171(1):98-108.
    View in: PubMed
    Score: 0.045
  36. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science. 2000 Oct 27; 290(5492):767-73.
    View in: PubMed
    Score: 0.043
  37. Catechol-O-methyltransferase inhibition attenuates levodopa toxicity in mesencephalic dopamine neurons. Mol Pharmacol. 2000 Mar; 57(3):589-94.
    View in: PubMed
    Score: 0.041
  38. Cytokine-induced conversion of mesencephalic-derived progenitor cells into dopamine neurons. Cell Tissue Res. 1999 May; 296(2):235-46.
    View in: PubMed
    Score: 0.039
  39. Dopamine-responsive neurotrophic factor in schizophrenia. Schizophr Res. 1995 Dec; 18(1):83-4.
    View in: PubMed
    Score: 0.030
  40. Cerebrospinal fluid from patients with Parkinson's disease alters the survival of dopamine neurons in mesencephalic culture. Exp Neurol. 1994 Mar; 126(1):15-24.
    View in: PubMed
    Score: 0.027
  41. Synaptic plasticity in the rat striatum following chronic haloperidol treatment. Clin Neuropharmacol. 1992 Dec; 15(6):488-500.
    View in: PubMed
    Score: 0.025
  42. An angiogenic inhibitor, cyclic RGDfV, attenuates MPTP-induced dopamine neuron toxicity. Exp Neurol. 2011 Sep; 231(1):160-70.
    View in: PubMed
    Score: 0.022
  43. Clozapine fails to prevent the development of haloperidol-induced behavioral hypersensitivity in a cotreatment paradigm. Eur J Pharmacol. 1990 Aug 02; 184(1):43-53.
    View in: PubMed
    Score: 0.021
  44. Investigations on auto-antibodies in Alzheimer's and Parkinson's diseases, using defined neuronal cultures. J Neural Transm Suppl. 1990; 29:195-206.
    View in: PubMed
    Score: 0.020
  45. Concurrent treatment with benztropine and haloperidol attenuates development of behavioral hypersensitivity but not dopamine receptor proliferation. Life Sci. 1988; 42(22):2207-15.
    View in: PubMed
    Score: 0.018
  46. Effects of dopamine antagonists and apomorphine on regional energy metabolism in rat CNS. Clin Neuropharmacol. 1987 Jun; 10(3):247-60.
    View in: PubMed
    Score: 0.017
  47. Altered glutathione homeostasis in animals prenatally exposed to lipopolysaccharide. Neurochem Int. 2007 Mar; 50(4):671-80.
    View in: PubMed
    Score: 0.016
  48. Animal models of tardive dyskinesia: their use in the search for new treatment methods. Mod Probl Pharmacopsychiatry. 1983; 21:5-20.
    View in: PubMed
    Score: 0.012
  49. Modification of central serotonergic and dopaminergic behaviors in the course of chronic corticosteroid administration. Eur J Pharmacol. 1982 Mar 12; 78(3):335-43.
    View in: PubMed
    Score: 0.012
  50. Long-term proliferation and dopaminergic differentiation of human mesencephalic neural precursor cells. Exp Neurol. 2001 Aug; 170(2):317-25.
    View in: PubMed
    Score: 0.011
  51. Peptide inhibitors of caspase-3-like proteases attenuate 1-methyl-4-phenylpyridinum-induced toxicity of cultured fetal rat mesencephalic dopamine neurons. Neuroscience. 1998 Oct; 86(3):701-7.
    View in: PubMed
    Score: 0.009
  52. Neuroleptic-induced dopamine hyposensitivity. Life Sci. 1984 Apr 09; 34(15):1475-9.
    View in: PubMed
    Score: 0.003
  53. Correlation between daily dosage of chlorpromazine and subsequent supersensitivity. Adv Biochem Psychopharmacol. 1980; 24:569-72.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.